| Аудиторские |  Игры |  Промышленность |  Торговля |  Нефтеные |  Строительство |  Трейдеры |  Инвестиционные |  Юридические |  Оффшорные |  Автомобили |  Страхование |  Комуникации |  Химические компании |  Программы | 
 
Johnson & Johnson (NYSE: JNJ)

Price and Chart delayed at least 15 mintues.
Price $ 55.98 Change 0.00
Open 0.00 % Change 0.0%
Prev Close 55.98 Volume NA
Market Value 154 bil P/E Ratio 12.2
Bid 55.55 EPS 4.57
Ask 55.86 Dividend 1.96
High 0.00 Yield 3.5
Low 0.00 Shares Out 2.76 bil
52wk High 72.76 52wk Low 46.25
Industry: Drug Manufacturers - Major
Sector: Healthcare

JNJ Profile

A holding company, which is engaged in the research and development, manufacture and sale of a range of products in the health care field.

Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
Phone: (732) 524-0400
Fax: (732) 214-0332
Web Site: www.jnj.com

JNJ Wires Headlines

07.05.09  'Brave' post-Lehman M&A rewarded by market -study
07.03.09  UPDATE 1-J&J says 84.4 pct of Cougar shares tendered
07.03.09  BRIEF-Johnson & Johnson says completes initial tender offer for Cougar Biotechnology
07.03.09  PRESS DIGEST - Wall Street Journal - July 3
07.02.09  Final Glance: Pharmaceuticals companies

More JNJ From Wires Headlines >

Forbes.com on JNJ     RSS

  • Commodities Slide
    • Oil falls more than $2; Johnson & Johnson take Elan stake.
  • Elan Sells A Chunk; Xilinx Stumbles
    • The Irish drug maker sells a stake in the business and launches new partnerships with Johnson & Johnson.
  • Jobs Report Rattles Stocks
    • Drop in nonfarm payrolls, unemployment at 9.5%.
  • In Pictures: 10 Life-Saving Technologies
    • Innovative medical gadgets that can save--or improve--your life

    JNJ Press Releases

    07.03.09  Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
    07.02.09  Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's...
    06.17.09  Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
    06.12.09  Biosense Webster to Support Landmark Clinical Trial of Atrial Fibrillation

    More JNJ Press Releases >

    JNJ Ratios & Returns

    Price-to-sales 2.46
    Return on Equity 29.4
    Operating Margin 30.2
    Profit Margin 20.5%

    More JNJ Ratios & Returns >

    JNJ Financials

    Sales $62.579 bil
    Profits $12.858 bil
    Assets $86.1 bil
    Employees 118700.0
Johnson & Johnson is ranked # 42 on the 2009 Forbes 2000 List

A D V E R T I S E M E N T




СМОТРЕТЬ
презентацию